Dr. Colin Doherty:

There is initial safety data but again it is on a relatively small number of products. That means even if we have it licensed we will always be watching and waiting, as the parents will be. Ms Twomey is the same. We are always watching and waiting in order to make sure. One could ask what happens if only one in 5,000 children who takes the drug dies. One could say there is a risk of death anyway. That is the choice we are making. That is the choice Ms Twomey is making. The families are making the choice. We consider the risk of death from the condition and the risk of death from the drug. We are always making that judgment.